Naturis Cosmetics, a B2B contract manufacturer in the beauty industry, is making waves with its recent funding round. The company has secured a substantial amount of Rs 33.74 crore ($3.5 million) led by Sharrp Ventures, with Mirabilis Investment Trust also participating. This funding marks a significant milestone for Naturis, as it is their maiden funding round, indicating a strong belief in the company's potential by investors.
What makes this deal particularly intriguing is the valuation Naturis Cosmetics is set to achieve. Post-money, the company is estimated to be valued at around Rs 364 crore or approximately $38 million. This valuation is impressive, especially considering the company's relatively recent founding in 2011. It highlights the growing demand for contract manufacturing services in the beauty industry and the trust investors have in Naturis' capabilities.
Naturis Cosmetics specializes in developing and manufacturing a wide range of personal care products, including skincare, haircare, fragrance, and cosmetics. They offer end-to-end services, from OEM/ODM to private label solutions, product formulation, R&D, packaging, manufacturing, and regulatory support. Their client list is impressive, featuring well-known beauty brands such as Nykaa, Plum, Purplle, Bare Anatomy, and Ustraa. This diverse client base speaks to Naturis' versatility and ability to cater to various market needs.
The funding will likely fuel Naturis' growth and expansion. With the additional capital, the company can enhance its production capabilities, invest in research and development, and potentially expand its team. This could lead to increased efficiency, innovation, and market reach. Additionally, the funding round might attract more clients, further solidifying Naturis' position as a leading contract manufacturer in the beauty industry.
One interesting aspect of this funding is the potential for a larger funding round in the future. An earlier report suggested that Naturis Cosmetics was aiming to raise a more substantial amount of Rs 80–100 crore. This indicates that the company has a long-term growth strategy and a clear vision for its future. It also showcases the confidence investors have in Naturis' ability to scale and dominate the market.
In conclusion, Naturis Cosmetics' maiden funding round is a significant development in the beauty industry. It highlights the growing demand for contract manufacturing services and the trust investors have in Naturis' capabilities. With this funding, Naturis is poised for growth, innovation, and market expansion. As the company continues to thrive, it will be fascinating to see how it shapes the future of the beauty industry's back-end operations.
